KR102122569B1 - 1-([1,3]디옥솔란-4-일메틸)-1η-피라졸-3-일아민을 제조하는 방법 - Google Patents
1-([1,3]디옥솔란-4-일메틸)-1η-피라졸-3-일아민을 제조하는 방법 Download PDFInfo
- Publication number
- KR102122569B1 KR102122569B1 KR1020157019691A KR20157019691A KR102122569B1 KR 102122569 B1 KR102122569 B1 KR 102122569B1 KR 1020157019691 A KR1020157019691 A KR 1020157019691A KR 20157019691 A KR20157019691 A KR 20157019691A KR 102122569 B1 KR102122569 B1 KR 102122569B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- methyl
- solvent
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012087380 | 2012-12-25 | ||
| CNPCT/CN2012/087380 | 2012-12-25 | ||
| PCT/EP2013/077563 WO2014102164A1 (en) | 2012-12-25 | 2013-12-20 | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20150100809A KR20150100809A (ko) | 2015-09-02 |
| KR102122569B1 true KR102122569B1 (ko) | 2020-06-15 |
Family
ID=49876646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157019691A Active KR102122569B1 (ko) | 2012-12-25 | 2013-12-20 | 1-([1,3]디옥솔란-4-일메틸)-1η-피라졸-3-일아민을 제조하는 방법 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9388168B2 (https=) |
| EP (1) | EP2938609B1 (https=) |
| JP (1) | JP6297590B2 (https=) |
| KR (1) | KR102122569B1 (https=) |
| CN (1) | CN105051031B (https=) |
| AU (1) | AU2013369473B2 (https=) |
| BR (1) | BR112015015229B1 (https=) |
| CA (1) | CA2896155C (https=) |
| CY (1) | CY1119040T1 (https=) |
| DK (1) | DK2938609T3 (https=) |
| ES (1) | ES2629313T3 (https=) |
| HR (1) | HRP20170653T1 (https=) |
| HU (1) | HUE032621T2 (https=) |
| IL (1) | IL239558A (https=) |
| LT (1) | LT2938609T (https=) |
| NZ (1) | NZ709362A (https=) |
| PL (1) | PL2938609T3 (https=) |
| PT (1) | PT2938609T (https=) |
| RU (1) | RU2621725C2 (https=) |
| SG (1) | SG11201504951TA (https=) |
| SI (1) | SI2938609T1 (https=) |
| WO (1) | WO2014102164A1 (https=) |
| ZA (1) | ZA201504601B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2728824C1 (ru) | 2016-12-15 | 2020-07-31 | Хуа Медсин (Шанхай) Лтд. | Препарат активатора глюкокиназы для перорального введения и способ его получения |
| CN113493442B (zh) * | 2020-04-03 | 2024-11-08 | 天津药物研究院有限公司 | 作为葡萄糖激酶活化剂的吡咯烷酮衍生物及其制备方法和用途 |
| US11813274B2 (en) | 2020-04-22 | 2023-11-14 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| WO2021212360A1 (en) * | 2020-04-22 | 2021-10-28 | Hua Medicine (Shanghai) Ltd. | Treating untreated or treatment-resistant diabetes with glucokinase activator and sodium-glucose cotransporter-2 inhibitor |
| CN111732543A (zh) * | 2020-08-14 | 2020-10-02 | 浙江鼎龙科技有限公司 | 一种4,5-二氨基-1-（2-羟乙基）吡唑硫酸盐的制备方法 |
| CN113750100B (zh) * | 2021-08-31 | 2022-12-30 | 海南中济医药科技有限公司 | 一种含有多扎格列艾汀与西格列汀的药物组合物及其制备方法 |
| AR127064A1 (es) * | 2021-09-15 | 2023-12-13 | Hua Medicine Shanghai Ltd | Prodroga de derivados de pirrolidona como activador de glucoquinasa |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160841A (en) * | 1977-01-31 | 1979-07-10 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
| FR2748274B1 (fr) * | 1996-05-03 | 1998-06-12 | Oreal | Nouveaux diamino pyrazoles, leur synthese, compositions de teinture des fibres keratiniques les contenant, procede de teinture des fibres keratiniques |
| AU2009205070A1 (en) | 2008-01-18 | 2009-07-23 | Astellas Pharma Inc. | Phenyl acetamide derivative |
| US7741327B2 (en) * | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
-
2013
- 2013-12-20 JP JP2015550041A patent/JP6297590B2/ja active Active
- 2013-12-20 RU RU2015126911A patent/RU2621725C2/ru active
- 2013-12-20 BR BR112015015229-5A patent/BR112015015229B1/pt active IP Right Grant
- 2013-12-20 EP EP13811542.3A patent/EP2938609B1/en active Active
- 2013-12-20 NZ NZ709362A patent/NZ709362A/en unknown
- 2013-12-20 PT PT138115423T patent/PT2938609T/pt unknown
- 2013-12-20 WO PCT/EP2013/077563 patent/WO2014102164A1/en not_active Ceased
- 2013-12-20 US US14/655,287 patent/US9388168B2/en active Active
- 2013-12-20 SG SG11201504951TA patent/SG11201504951TA/en unknown
- 2013-12-20 KR KR1020157019691A patent/KR102122569B1/ko active Active
- 2013-12-20 LT LTEP13811542.3T patent/LT2938609T/lt unknown
- 2013-12-20 ES ES13811542.3T patent/ES2629313T3/es active Active
- 2013-12-20 SI SI201330684A patent/SI2938609T1/sl unknown
- 2013-12-20 CN CN201380068179.8A patent/CN105051031B/zh active Active
- 2013-12-20 HR HRP20170653TT patent/HRP20170653T1/hr unknown
- 2013-12-20 PL PL13811542T patent/PL2938609T3/pl unknown
- 2013-12-20 DK DK13811542.3T patent/DK2938609T3/en active
- 2013-12-20 HU HUE13811542A patent/HUE032621T2/en unknown
- 2013-12-20 AU AU2013369473A patent/AU2013369473B2/en active Active
- 2013-12-20 CA CA2896155A patent/CA2896155C/en active Active
-
2015
- 2015-06-21 IL IL239558A patent/IL239558A/en active IP Right Grant
- 2015-06-25 ZA ZA2015/04601A patent/ZA201504601B/en unknown
-
2017
- 2017-07-10 CY CY20171100727T patent/CY1119040T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102122569B1 (ko) | 1-([1,3]디옥솔란-4-일메틸)-1η-피라졸-3-일아민을 제조하는 방법 | |
| CN102770420B (zh) | 制备决奈达隆的新方法 | |
| KR20170131508A (ko) | 레디파스비르 및 이의 유도체의 제조방법 및 레디파스비르를 제조하기 위한 중간체 화합물 | |
| JP4330836B2 (ja) | ピペラジン誘導体の製造方法 | |
| CN1044810C (zh) | 新药多索茶碱的合成方法 | |
| RU2557236C2 (ru) | Способ получения соединений 2-(1-фенилэтил)изоиндолин-1-она | |
| JP5139104B2 (ja) | ジベンゾオキセピン化合物の製造方法 | |
| WO2016095662A1 (zh) | (2S，3R，4R)-3，5-二取代-2-脱氧-2-羟基-2-甲基-D-核糖-γ-内酯的制备方法及其中间体 | |
| WO2020171073A1 (ja) | ベンゾアゼピン誘導体の製造方法及びその中間体 | |
| KR100301335B1 (ko) | 알파-아릴-감마-부티로락톤의제조방법 | |
| KR101842425B1 (ko) | 시탈로프람 및 에스시탈로프람의 신규 제조방법 | |
| HK1213262B (en) | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine | |
| KR20230160303A (ko) | ５－｛５－클로로－２－[(3s)－３－[(모르폴린－４－일)메틸]－３,４－디하이드로이소퀴놀린－２(１ｈ)－카르보닐]페닐｝－１,２－디메틸－１ｈ－피롤－３－카르복실산 유도체의 신규한 합성 방법 및 약학적 화합물의 생산을 위한 이의 용도 | |
| CN116348470A (zh) | 八氢噻吩并喹啉化合物的制造方法和其制造中间体 | |
| CN101687859A (zh) | 阿呋唑嗪及其盐的制备工艺 | |
| KR20050103610A (ko) | 염산 프로피베린의 신규한 제조방법 | |
| JP2000344742A (ja) | ３−アミノ−１−フェニルピロリジン−２−オン誘導体の製造方法 | |
| JP2002371049A (ja) | ３，３−ジアルコキシ−２−ヒドロキシイミノ誘導体及びその製造法 | |
| JP2013006804A (ja) | ベンゾフェノン誘導体の製造法 | |
| JP2016503068A (ja) | パピローマウイルスの治療で用いることができるヒドラジンの合成方法 | |
| JPH11209365A (ja) | β，γ−不飽和カルボン酸誘導体の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20150720 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20181105 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200123 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200525 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200608 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20200609 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20240502 Start annual number: 5 End annual number: 5 |